In this talk at the 2024 Liquid Biopsy for Precision Oncology Summit, BLOODPAC’s Executive Director Lauren C. Leiman will discuss the consortium’s work in:

• Investigating the use of liquid biopsy for diagnosis and determining disease severity

• Discussing recent collaborations and new guidelines for standardizations to set a regulatory precedent

• Furthering global implementation of frameworks and standards

• Evolving to support the community with emerging trends and technologies in liquid biopsy